Submission Details
| 510(k) Number | K240880 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 01, 2024 |
| Decision Date | September 12, 2024 |
| Days to Decision | 164 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K240880 is an FDA 510(k) clearance for the VitalFlow Set with Balance Biosurface, a Extracorporeal System For Long-term Respiratory / Cardiopulmonary Failure (Class II — Special Controls, product code QJZ), submitted by Medtronic, Inc. (Minneapolis, US). The FDA issued a Cleared decision on September 12, 2024, 164 days after receiving the submission on April 1, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.4100.
| 510(k) Number | K240880 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 01, 2024 |
| Decision Date | September 12, 2024 |
| Days to Decision | 164 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | QJZ — Extracorporeal System For Long-term Respiratory / Cardiopulmonary Failure |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.4100 |
| Definition | Extracorporeal Circuit And Accessories For Long-term Respiratory/cardiopulmonary Failure. |